Medigen Vaccine Biologics Corp (高端疫苗) yesterday reported net profit of NT$1.41 billion (US$50.3 million) for last year and its board of directors approved a plan to distribute a stock dividend of NT$5 per share, a company regulatory filing showed.
The company turned a profit for the first time last year, thanks to sales of 5 million doses of its COVID-19 vaccine to the Ministry of Health and Welfare, and a government subsidy of NT$470 million for human testing.
Medigen, which began selling its COVID-19 vaccine in the second half of last year after being granted an emergency use authorization in July, reported that revenue expanded 298-fold to NT$3.28 billion, up from NT$11 million in 2020.
Photo: Tsai Szu-pei, Taipei Times
Earnings per share were NT$6.65 last year, compared with losses per share of NT$3.61 in 2020, the company said.
The dividend payout would be subject to shareholders’ approval at an annual general meeting on June 30, it said.
The board of directors also approved a proposal to raise funds by issuing 7 million new common shares, as the company aims to continue expanding production capacity, Medigen said.
The company expects to raise NT$1.75 billion via the new share issuance and obtain another NT$1.75 billion via a new bond issuance, it said.
Medigen expects to receive more international orders for its COVID-19 vaccine this year and aims to produce 100 million doses this year, it said.
UNCONVINCING: The US Congress questioned whether the company’s Chinese owners pose a national security risk and how the app might influence young users TikTok chief executive officer Shou Chew (周受資), confronted with an unforgiving, distrustful US Congress, tried to give answers in his testimony on Thursday that avoided offending either the US government or China. However, his evasiveness left Congress unsatisfied, with representatives hungrier than ever to punish TikTok for ties to its parent company ByteDance Ltd (字節跳動), based in Beijing. He did not bring his company any closer to a resolution. Politically, TikTok is in a tougher spot. Its executives had been discussing divesting from ByteDance to resolve US national security concerns, people familiar with the matter told Bloomberg. However, China this week said
Microsoft Corp has threatened to cut off access to its Internet search data, which it licenses to rival search engines, if they do not stop using it as the basis for their own artificial intelligence (AI) chat products, people familiar with the dispute have said. The software maker licenses the data in its Bing search index — a map of the Internet that can be quickly scanned in real time — to other companies that offer Web search, such as Apollo Global Management Inc’s Yahoo and DuckDuckGo. Last month, Microsoft integrated a cousin of ChatGPT, OpenAI’s AI-powered chat technology, into Bing. Rivals
Sanofi SA’s drug Dupixent succeeded in a late-stage trial for chronic obstructive pulmonary disease (COPD), raising the odds that the blockbuster would be the first biologic medicine cleared to treat the lung disorder. Dupixent, which is already prescribed for asthma and some skin conditions, showed a 30 percent reduction in the rate at which patients’ COPD worsened compared with those who received a placebo during the stage-three Boreas trial, the company said in a statement yesterday. The positive data could herald a new era of cutting-edge treatments for the life-threatening respiratory affliction and provide another major boost in demand for the French
SEMICONDUCTOR EQUIPMENT: The international trade group said the sector would recover from a slump, with spending expected to rise 4.2 percent to US$24.9 billion Taiwan is to retain its position as the top spender on semiconductor front-end equipment and facilities next year, with spending expected to increase 4.2 percent year-on-year to US$24.9 billion, international trade group SEMI said yesterday. The spending forecast matches an expected recovery in global semiconductor equipment and facilities investment next year, it said. International equipment spending is to return to growth next year, SEMI said in a report, forecasting 21 percent growth to US$92 billion. The expansion would manly be driven by robust demand for semiconductors in the automotive and high-performance computing segments, the association said. “This quarter’s SEMI World Fab Forecast update
RSS